- Macerich’s adjusted Funds From Operations (FFO) per share was 33 cents, missing the estimate of 34 cents and down from 37 cents year-over-year.
- Reported FFO per share was 32 cents, a decline from 44 cents in the same period last year.
- The total occupancy of their centers was 92%, slightly down from 93.3% the previous year, and below the estimate of 92.6%.
- Total revenue was $249.8 million, representing an impressive 16% increase from the previous year, surpassing the estimate of $227.2 million.
- Analyst recommendations include 6 buys, 9 holds, and 3 sells for Macerich.
A look at Macerich Co/The Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on Smartkarma Smart Scores, Macerich Co/The demonstrates strength in value and dividend aspects, scoring high marks in both categories. This indicates that the company is perceived positively in terms of its value proposition and potential for providing stable dividends. However, in terms of growth, resilience, and momentum, Macerich Co/The receives lower scores, suggesting potential challenges in these areas. As a fully integrated real estate investment trust, The Macerich Company focuses on acquiring and managing shopping centers across the United States.
Looking towards the long-term outlook for Macerich Co/The, its strong performance in value and dividends may attract investors seeking stability and income. However, the lower scores in growth, resilience, and momentum indicate areas where the company may need to focus on improving. Overall, investors may want to consider a balanced approach when evaluating Macerich Co/The, taking into account its strengths in value and dividends alongside areas of potential concern in growth and resilience.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
